ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 12

Delta-like 1 Enhances the Production of Pro-Inflammatory Mediators By Fibroblast-like Synoviocytes

Chiyoko Sekine, Department of Clinical Research Medicine, Teikyo University School of Medicine, Tokyo, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fibroblasts, Inflammation, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Notch signaling is known to regulate cell fate decision and differentiation during embryonic and post-natal development. I have been reported that a Notch ligand Delta-like 1 (DLL1) promoted osteoclastogenesis via Notch2 activation and DLL1 blockade in rheumatoid arthritis (RA) model mouse reduced the number of osteoclasts in the affected joints. This DLL1 blockade also suppressed the joint inflammation by suppressing the production of pro-inflammatory mediators such as IL-6, GM-CSF, and MMP-3. In arthritic mouse joint, DLL1 expressed on macrophages and stimulated Notch2 on fibroblast-like synoviocytes (FLS), which enhanced the production of IL-6 and MMP-3. In this study, the role of DLL1 on the production of pro-inflammatory mediators by RA FLS was evaluated.

Methods: The expression of Notch receptors and ligands on RA FLS was analyzed by flow cytometry. OA FLS was also analyzed. DLL1 expression was investigated by imunohistochemical analysis of synovial tissue. FLS were stimulated with anti-Notch2 monoclonal antibody or DLL1-transfected CHO cells and IL-6, GM-CSF, and MMP-3 in the supernatants were measured by ELISA.

Results: As similar to mouse joint cells, Notch2 was expressed on RA-derived FLS and DLL1 was expressed on macrophages in RA synovium but not on FLS. Meanwhile, little expression of Notch2 was detected on osteoarthritis-derived FLS.  Activation of Notch2 on RA FLS enhanced the production of IL-6 and GM-CSF. DLL1 stimulation also enhanced the production of IL-6, GM-CSF, and MMP-3 by RA FLS. 

Conclusion: These results suggest that DLL1 activates Notch2 on RA FLS and enhances the production of RA-related pro-inflammatory mediators similar to mouse FLS. Therefore, DLL1 blockade may be a novel strategy to treat RA by suppressing the production of pro-inflammatory mediators in the joint as well as osteoclastogenesis.


Disclosure: C. Sekine, None;

To cite this abstract in AMA style:

Sekine C. Delta-like 1 Enhances the Production of Pro-Inflammatory Mediators By Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/delta-like-1-enhances-the-production-of-pro-inflammatory-mediators-by-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/delta-like-1-enhances-the-production-of-pro-inflammatory-mediators-by-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology